In 2017, approximately 6 out of 10 prisoners reported using illicit drugs in the past, most frequently cannabis, followed by stimulants, opioids and misused benzodiazepines.
The national strategy for drug-related treatment in prison is based on the ‘import model’, in which external providers offer drug treatment in close collaboration with the Prison and Probation Service’s staff. Drug treatment is provided on the basis of the principles of equity and continuity of care. Quality assurance criteria for treatment are the same in and out of prison. Prisons have introduced a treatment guarantee stipulating that treatment should be provided to all inmates who request it within 2 weeks. Treatment is available through health and social programmes, which include motivation, pre-treatment assistance, intensive inpatient treatment in special treatment units, opioid substitution treatment (OST), post-treatment programmes and treatment of withdrawal symptoms. Special programmes for those who use cannabis, cocaine and other stimulants are available. OST and other long-term drug treatment programmes are coordinated with public treatment services to ensure continuation in the post-release period. Drug-free prison wings are also available.
To prevent drug-related infectious diseases, chlorine is available for disinfection, and vaccination against hepatitis A and B viruses is also provided.